Concurrent chemoradiotherapy with conventional fractionated radiotherapy and low-dose daily cisplatin plus weekly docetaxel for T2N0 glottic cancer

BACKGROUND: To assess the efficacy of concurrent chemoradiotherapy (CCRT) with daily low-dose cisplatin (CDDP) plus weekly docetaxel (DTX) for patients with T2N0 glottic cancer. METHODS: Between January 2004 and December 2013, 62 treatment-naive patients with histologically proven T2N0 glottic cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Saitoh, Jun-ichi, Shirai, Katsuyuki, Imaeda, Masumi, Musha, Atsushi, Abe, Takanori, Shino, Masato, Takayasu, Yukihiro, Takahashi, Katsumasa, Chikamatsu, Kazuaki, Nakano, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319079/
https://www.ncbi.nlm.nih.gov/pubmed/28219396
http://dx.doi.org/10.1186/s13014-016-0741-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319079/
https://www.ncbi.nlm.nih.gov/pubmed/28219396
http://dx.doi.org/10.1186/s13014-016-0741-4

Ejemplares similares